Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study
ConclusionsThyroid alterations are frequently associated with anti PD-1 treatment in cancer patients. Regular thyroid assessment should be performed, particularly in the first months of treatment and in patients with a pre-existing thyroid disease.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Cancer | Cancer & Oncology | Diabetes | Diabetes Mellitus | Endocrinology | Immunotherapy | Kidney Cancer | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Skin Cancer | Study | Thyroid | Thyroid Cancer | Toxicology | Urology & Nephrology